Latest Trading Halts News

WCM Global Growth has secured full underwriting for its $6.5 million Dividend Reinvestment Plan tied to a fully franked 2.35 cents per share final dividend. The issue price is due on 22 September, with the new shares scheduled for issue eight days later.

Flynn Gold has been suspended from trading while it prepares to announce a capital raising, leaving investors without details on the size, pricing or potential dilution. The company expects normal trading to resume by 18 September 2026, unless the announcement is released sooner.

Minerals 260 has secured an additional $200 million funding package from Franco-Nevada for its 6.2Moz Bullabulling Gold Project, including $170 million in royalty funding and a planned $30 million equity subscription. The deal strengthens project financing, but the future equity raising and higher royalty burden remain important details for shareholders.

Alara Resources has told ASX it knows of no undisclosed information behind a sharp rise in its share price and trading volume. The company said its response was approved by Executive Chair Peter Lee and confirmed compliance with continuous disclosure rules.

Native Mineral Resources has told ASX it is unaware of any undisclosed information behind recent trading in its shares. The company pointed to record August gold output, a Citigold joint venture, Blackjack drilling results and stronger gold prices instead.

Leeuwin Metals has rejected the possibility of undisclosed exploration results driving a sharp rise in its share price, after ASX queried the move from $0.22 to $0.295. The gold explorer pointed instead to recent Marda news, a company-funded research report, stronger gold prices and buying by a substantial holder.

Revolver Resources says it knows of no undisclosed information behind a sharp rise in its shares and trading volume. The company pointed only to ongoing work at the Dianne Copper Mine and progress towards a positive Final Investment Decision.

NuEnergy Gas Limited has secured A$3.05 million through a placement to fund early gas sales and production expansion at its Tanjung Enim project, alongside advancing other Indonesian coal bed methane assets.

Actinogen Medical (ASX:ACW) has clarified that no undisclosed information explains recent unusual trading in its shares, pointing instead to recent underwriting of options and published updates. The biotech also reaffirmed compliance with ASX rules and provided a detailed update on its lead Alzheimer’s drug Xanamem and ongoing clinical trials.

Percheron Therapeutics has raised $2.3 million through an institutional placement to fully fund its upcoming acute myeloid leukemia clinical trial led by Vanderbilt Health.

West Coast Silver has raised $6 million through an oversubscribed placement, enhancing its capacity to advance exploration and development at the high-grade Elizabeth Hill silver project.

Alliance Aviation Services has completed the institutional portion of its $40 million equity raise, securing $33 million to support its turnaround and debt reduction efforts. The retail entitlement offer opens in early September.